CBRE Group
CBRE
$134.79
-2.45%
CBRE Group is the world's largest commercial real estate services and investment firm, generating revenue across advisory (leasing and capital markets brokerage), project and facilities management, valuation, mortgage servicing, and investment management for occupiers and investors spanning every major property type and more than 100 countries. Its scale, global footprint, and roughly 155,000 employees give it a data and relationships moat that positions it as the industry's dominant platform rather than a niche specialist, though that leadership also makes it a high-beta proxy on commercial real estate transaction volumes and corporate real estate spending. The current investor debate centers on two competing narratives: a cyclical recovery in capital markets activity and leasing that has driven double-digit revenue growth (Q3 2026 revenue up 12.3% year over year), versus a stock that has badly lagged the market amid rate and CRE credit concerns. The October 2026 acquisition of Onnec Group — a move into data center infrastructure services tied to the AI buildout — has become the freshest catalyst, with bulls framing it as an immediately accretive adjacency to CBRE's project management franchise while skeptics question integration risk and whether AI-driven demand can offset softer traditional brokerage economics.…
CBRE
CBRE Group
$134.79
Related headlines
Investment Opinion: Should I buy CBRE Today?
Rating: Buy (accumulate on weakness). The core thesis is that CBRE — the world's largest commercial real estate services platform — is priced for a cyclical trough that the fundamentals are already disproving: Q3 2026 revenue grew 12.27% YoY to $11.517 billion, forward EPS of $13.48 puts the stock at just 15.29x, and all 12 covering analysts rate it Buy with an average target of $172.00 (+26.9% upside) and a low target of $141.00 that still sits 4.1% above the $135.51 price. The market is paying 41.44x trailing earnings for a business whose forward multiple collapses by roughly 63% if consensus earnings arrive, a classic trough-valuation setup rather than a value trap.
Supporting evidence is broad: revenue has compounded sequentially from $10.53B to $11.23B to $11.52B across 2026 quarters, with fee-based Advisory ($2.441B) and Project Management ($2.035B) carrying growth; Q3 operating income of $561M (4.87% margin) rebounded from Q2's $365M (3.25%); TTM free cash flow of $938M and ROE of 13.03% confirm the capital-light model still generates cash; and the October Onnec acquisition adds an immediately accretive data-center infrastructure adjacency tied to the AI buildout. Against the sector, price-to-sales of 1.18x and EV/sales of 1.09x are modest for a 12%+ grower, even as price-to-book of 5.40x sits near the top of its 2.7x–5.5x historical band.
The biggest risks are margin fragility (3.85% net margin, gross margin swinging 15.29%–18.58%), leverage (debt-to-equity 1.125, current ratio 1.095), and a beta of 1.227 that amplifies any CRE credit shock. The rating would upgrade to a stronger Buy if the stock reclaims the $150–$155 resistance zone on margin expansion, and would downgrade to Hold if revenue growth decelerates below 10% or gross margin falls under 15%. Verdict: undervalued on forward earnings and relative to its own history, fairly-to-richly valued on trailing cash flow — a Buy for investors with a 12–18 month horizon who can tolerate a retest of the $121 support.
Sign up to view all
CBRE 12-Month Price Forecast
The forward-looking case is constructive: CBRE trades at 15.29x forward earnings against a 41.44x trailing multiple, a gap that only closes if the $13.48 consensus EPS is delivered — and the 12.27% Q3 revenue growth, rebounding operating margin (4.87% vs. 3.25% in Q2), and unanimous Buy consensus with every target above the current price suggest the selloff has overshot. The Onnec deal provides a fresh growth narrative decoupled from traditional CRE transaction volumes, while the +11.22% one-month relative strength versus SPY hints sentiment is turning. Confidence is medium rather than high because the thesis hinges on margin recovery in a labor-intensive model with thin 3.85% net margins and leverage of 1.125x debt-to-equity. An upgrade to high confidence would come from a Q4 beat with operating margin above 5% and a break above $155; a downgrade to neutral would follow a break below $121 or revenue growth decelerating below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $172.00 and implied upside of +27.6% versus the current price.
Average Target
$172.00
13 analysts
Implied Upside
+27.6%
vs. current price
Analyst Count
13
covering this stock
Price Range
$141 - $200
Analyst target range
Coverage is robust and overwhelmingly bullish: 12 analysts rate the stock, with 12 Buy, 1 Hold, and 0 Sell, yielding a consensus recommendation of "buy" and a recommendation mean of 1.54 (where 1.0 is a strong buy). The average target price of $172.00 implies roughly +26.9% upside from the current $135.51, and even the lowest target of $141.00 sits about 4.1% above the current price — meaning every published target is above the market, a rare unanimity that signals the sell-side views the recent selloff as an overreaction. The consensus leans clearly bullish, and the fact that the stock trades below the low end of the target range is a notable dislocation.\n\nThe target range of $141.00 to $200.00 is wide — a 42% spread from low to high — indicating meaningful disagreement about the magnitude of the recovery even as direction is agreed upon. The $200 high target likely assumes multiple expansion back toward historical norms plus successful Onnec integration and accelerating AI-driven data center demand, while the $141 low target prices in a more modest earnings recovery with limited re-rating. Institutional ratings show a pattern of steady reaffirmation rather than fresh upgrades — Evercore ISI (Outperform, October 23), Keefe Bruyette & Woods (Outperform, October 9), Barclays (Overweight, August 17), and UBS (Buy, July 30) have all maintained bullish stances through the drawdown, with no downgrades in the visible record. That consistency, combined with the 12-to-1 Buy/Hold ratio and the stock trading below the lowest target, suggests strong conviction that the current price embeds an overly pessimistic view of CBRE's cyclical and AI-infrastructure opportunity.
Drowning in data?
Find the real signal!
Bulls vs Bears: CBRE Investment Factors
The bear case currently has stronger price-action evidence — a 15.41% YTD decline, -23.24% relative strength versus the S&P, and a stock pinned near the bottom of its 52-week range — while the bull case rests on forward-looking fundamentals: 12.27% revenue growth, a 15.29x forward PE, and a sell-side consensus where all 13 analysts are Buy/Hold and every target exceeds the current price. The most important tension is whether the earnings step-up embedded in the $13.48 consensus EPS actually arrives; if margin recovery and Onnec accretion deliver it, the stock is cheap, but if margin pressure persists, the 41.44x trailing multiple is a warning. The recent +11.22% one-month relative strength and 16% rebound off $121.65 suggest sentiment is beginning to turn, but it remains a bounce within an intact intermediate downtrend rather than a confirmed reversal. Net-net, the fundamental and analyst evidence edges out the technical weakness, but only conditionally — the thesis is a bet on cyclical CRE recovery and AI-infrastructure execution, not on current momentum.
Bullish
- Every analyst target sits above price: The lowest published target of $141.00 is 4.1% above the $135.51 current price, and the $172.00 average implies +26.9% upside, with 12 Buy ratings against 1 Hold and 0 Sell (recommendation mean 1.54). This unanimity — a stock trading below the entire target range — is a rare dislocation that suggests the selloff has overshot fundamentals.
- Forward PE of 15.3x is cheap: The trailing PE of 41.44x collapses to 15.29x on consensus EPS of $13.48, a 63% compression that implies the market is pricing a substantial earnings step-up. If that normalization materializes, CBRE trades at a discount to broad market multiples despite being the industry's dominant platform.
- Double-digit revenue growth persists: Q3 2026 revenue of $11.517 billion rose 12.27% YoY, following +15.1% in Q2 and +18.1% in Q1, with sequential revenue climbing $10.53B to $11.23B to $11.52B. Resilient fee-based advisory ($2.441B) and project management ($2.035B) segments are carrying growth even while transactional brokerage stays rate-sensitive.
- Onnec adds AI data-center catalyst: The October 2026 Onnec Group acquisition pushes CBRE into data center infrastructure services tied to the AI buildout, framed as immediately accretive and an adjacency to the $2.035 billion project management franchise. It gives the stock a growth narrative decoupled from traditional CRE transaction volumes.
Bearish
- Severe relative underperformance: CBRE is down 9.65% over one year and 15.41% YTD versus SPY's +9.59% and +7.83%, producing relative strength of -19.24% and -23.24%. The stock sits at just 26.6% of its 52-week range ($121.44–$174.27), closer to the floor than the ceiling, with a 29.11% max drawdown confirming real capital destruction.
- Trailing valuation looks expensive: The trailing PE of 41.44x, EV/EBITDA of 22.02x, PEG of 1.82, and price-to-cash-flow of 30.75x are rich on absolute cash-flow terms, and price-to-book of 5.40x sits near the top of its historical 2.7x–5.5x band. The bull case rests entirely on forward earnings that have not yet been delivered.
- Razor-thin, volatile margins: Q3 net margin was 3.85% and operating margin 4.87%, with gross margin swinging from 15.29% in Q4 2025 to 18.58% in Q2 2026. In a labor-intensive model facing wage inflation, small margin slippage can erase a large share of earnings — Q2 operating income of $365M (3.25% margin) versus Q3's $561M shows the volatility.
- Growth is decelerating: YoY revenue growth has slowed from ~18.1% in Q1 to ~15.1% in Q2 to 12.27% in Q3, a clear downward trajectory. If this deceleration continues into 2027, the mid-teens growth embedded in the $62.2 billion consensus revenue estimate and the 15.29x forward multiple would both come under pressure.
CBRE Technical Analysis
CBRE is in a choppy, range-bound consolidation with a distinctly negative longer-term tilt: the stock is down 9.65% over the past year and 15.41% year to date, a stark underperformance versus the S&P 500's +9.59% 1-year and +7.83% YTD returns (relative strength of -19.24% and -23.24%, respectively). At $135.51, the shares sit at roughly 26.6% of the 52-week range of $121.44–$174.27 — closer to the floor than the ceiling — which flags a stock that has repeatedly failed to hold rallies rather than one pressing against highs. The 29.11% max drawdown confirms meaningful capital destruction over the trailing year, and the positioning implies investors are treating bounces as selling opportunities until proven otherwise.\n\nShort-term momentum has turned sharply positive and now diverges from the longer-term downtrend: the stock is up 6.23% over the past month versus a -4.99% decline in SPY, producing a relative strength reading of +11.22% — one of the strongest one-month spreads in the data set. That bounce follows a capitulation low near $121.65 on October 27 and a subsequent snap-back to $141.11 by November 4, a roughly 16% rebound in six sessions, before easing to $135.51. The 3-month change of -8.55% (versus SPY -4.91%) shows the one-month surge is a recovery within a still-intact intermediate downtrend, a classic mean-reversion pattern off oversold conditions rather than a confirmed trend reversal — the divergence signals a tradeable bounce but not yet a durable inflection.\n\nKey technical levels are well defined: support sits at the 52-week low of $121.44, with the October swing low of $121.65 reinforcing that zone as the line in the sand, while resistance lies at the 52-week high of $174.27, with intermediate supply likely in the $150–$155 area where the stock stalled repeatedly in August (peaks of $155.07 and $152.86). A decisive break above $155 would suggest the market is re-rating the CRE recovery and AI-infrastructure story, whereas a breakdown below $121 would confirm the downtrend and likely trigger momentum-driven selling. With a beta of 1.227, CBRE is roughly 23% more volatile than the market, meaning position sizing should assume amplified drawdowns — the 29.11% max drawdown versus a modest index decline illustrates exactly that asymmetry.\n\n
Beta
1.23
1.23x market volatility
Max Drawdown
-29.1%
Largest decline past year
52-Week Range
$121-$174
Price range past year
Annual Return
-11.2%
Cumulative gain past year
| Period | CBRE Return | S&P 500 |
|---|---|---|
| 1m | +3.1% | -3.7% |
| 3m | -8.6% | -2.9% |
| 6m | +1.8% | +0.2% |
| 1y | -11.2% | +10.1% |
| ytd | -15.9% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CBRE Fundamental Analysis
Revenue is growing at a healthy clip and the trajectory is stable-to-improving: Q3 2026 revenue of $11.517 billion rose 12.27% year over year from $10.258 billion, following $11.226 billion in Q2 (+15.1% YoY vs. $9.753 billion) and $10.527 billion in Q1 (+18.1% YoY vs. $8.910 billion), with Q4 2025 at $11.629 billion. The sequential cadence — $10.53B, $11.23B, $11.52B — shows consistent top-line expansion, and the segment mix (Advisory Services $2.441 billion, Project Management $2.035 billion, Real Estate Investments $203 million) confirms the resilient, fee-based advisory and outsourcing businesses are carrying growth even as transactional brokerage remains rate-sensitive. The deceleration in YoY growth from ~18% in Q1 to ~12% in Q3 is worth monitoring, but the absolute dollar progression and the Onnec data-center acquisition support a case for continued mid-teens growth into 2027, consistent with consensus revenue estimates of $62.2 billion.\n\nProfitability is solid but margin-thin, typical of a services intermediary: Q3 2026 net income was $443 million on a 3.85% net margin, with gross margin of 18.45% and operating margin of 4.87%, while the trailing metrics show a 2.85% net margin and 3.19% operating margin. Margins have been volatile quarter to quarter — gross margin was 18.58% in Q2, 17.59% in Q1, and 15.29% in Q4 2025 — but the Q3 operating income of $561 million (4.87% margin) improved from Q2's $365 million (3.25%) and Q1's $511 million (4.85%), suggesting cost discipline is holding despite wage inflation in a labor-intensive model. The Q3 EPS of $1.53 (diluted $1.52) versus $0.69 in Q2 and $1.08 in Q1 shows strong seasonal back-loading, and the full-year consensus EPS of $13.48 implies the earnings base is intact even as the stock de-rates.\n\nThe balance sheet is levered but manageable for the business model: debt-to-equity of 1.125, a current ratio of 1.095, and cash of $1.82 billion at Q3 against $869 million of quarterly operating cash flow and $743 million of free cash flow (TTM FCF $938 million). Cash generation is lumpy — Q1 2026 operating cash flow was -$825 million on working capital swings, Q2 just $138 million, then Q3 rebounded to $869 million — reflecting the seasonal receivables cycle of a brokerage, but the TTM FCF of $938 million against a $47.9 billion market cap yields only ~2.0%, and the $30.75 price-to-cash-flow ratio underscores how richly the market still values that cash stream. ROE of 13.03% and ROA of 2.40% are respectable for a capital-light intermediary, and with $218 million of buybacks in Q3 and no dividend, capital allocation leans toward reinvestment and M&A (Onnec) rather than shareholder returns — a growth-oriented but leverage-dependent posture.\n\n
Quarterly Revenue
$11.5B
2026-09
Revenue YoY Growth
+12.3%
YoY Comparison
Gross Margin
18.4%
Latest Quarter
Free Cash Flow
$938000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CBRE Overvalued?
Because CBRE is profitable (Q3 net income of $443 million, TTM EPS positive), the PE ratio is the appropriate primary metric: the trailing PE of 41.44x looks demanding, but the forward PE of 15.29x — based on consensus EPS of $13.48 — collapses the multiple by roughly 63%, a gap that implies the market expects a substantial earnings step-up (likely from margin recovery and Onnec accretion) rather than multiple expansion. The PEG ratio of 1.82 and EV/EBITDA of 22.02x suggest the stock is not cheap on absolute cash-flow terms, but the forward earnings discount is the crux of the bull case.\n\nAgainst the Real Estate sector, CBRE's 1.18x price-to-sales and 1.09x EV/sales are modest for a services platform, though its 5.40x price-to-book and 22.0x EV/EBITDA sit at a premium to typical asset-heavy REIT comparables — a premium that is arguably justified by CBRE's capital-light, fee-based model and 12%+ revenue growth versus the low-single-digit growth of property owners. The 15.29x forward PE versus a 41.44x trailing PE implies the market is pricing a normalization of earnings power; if that materializes, the stock trades at a discount to broad market multiples, but if margin pressure persists, the trailing multiple is a warning sign.\n\nHistorically, CBRE's PE has ranged from roughly 12x (Q3 2022) to 60x+ (Q1 2025), with the current 41.44x trailing sitting in the upper-middle of that band but well below the 2025 peak, while the price-to-sales of 1.18x is near the low end of its multi-year 2.9x–4.6x range — a divergence that reflects the earnings compression rather than a sales collapse. The price-to-book of 5.40x is near the top of its historical 2.7x–5.5x band, suggesting the market still ascribes premium franchise value to the platform. Net-net, the stock looks expensive on trailing earnings and cheap on forward earnings, a classic cyclical-trough setup where the valuation verdict hinges entirely on whether the CRE recovery and AI-infrastructure pivot deliver the earnings rebound embedded in the 15.29x forward multiple.\n\n
PE
41.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~74x
vs. Industry Avg
26.2x
Industry PE ~26.2x*
EV/EBITDA
22.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on thin margins and leverage in a labor-intensive model. Q3 operating margin of 4.87% and net margin of 3.85% leave little buffer, and gross margin has swung between 15.29% and 18.58% over the past four quarters, so wage inflation or a transactional slowdown could compress earnings sharply — Q2 operating income of $365 million (3.25% margin) versus Q3's $561 million illustrates that volatility. Debt-to-equity of 1.125 and a current ratio of 1.095 provide limited cushion, while operating cash flow swung from -$825 million in Q1 to $869 million in Q3, and TTM free cash flow of $938 million yields only ~2.0% on the market cap. Revenue is also concentrated in cyclical brokerage and capital markets activity, meaning a stall in CRE transaction volumes would hit the highest-margin advisory line directly.
Market and competitive risks are dominated by valuation compression and macro sensitivity. The trailing PE of 41.44x and EV/EBITDA of 22.02x are premium multiples that depend on the forward EPS of $13.48 materializing; any disappointment would force a de-rating toward the 12x historical low seen in Q3 2022. With a beta of 1.227, CBRE is roughly 23% more volatile than the market, amplifying drawdowns if rates stay elevated and CRE credit concerns persist — the stock's -23.24% YTD relative strength versus the S&P already reflects this. The Onnec integration adds execution risk, and the AI-driven rotation highlighted in recent market commentary (February 2026 selloffs in real estate and tech) shows how quickly sector sentiment can shift against the name.
In a worst-case scenario, a CRE credit event or a stall in capital markets activity would combine with margin compression and Onnec integration missteps to break the $121.44 52-week low, with the October 27 swing low of $121.65 reinforcing that zone as the line in the sand. From the current $135.51, a retest of the 52-week low implies roughly -10.4%, and a deeper breakdown toward the 12x historical PE floor on lower earnings could extend losses toward -25% to -30%, consistent with the 29.11% max drawdown already experienced over the trailing year. The bear-case analyst target of $141.00 is actually above the current price, so the true downside is defined by technical support and multiple compression rather than published targets — a break below $121 would likely trigger momentum-driven selling and confirm the downtrend.
FAQ
Ranked by severity, the first risk is financial fragility: net margin of 3.85% and operating margin of 4.87% in a labor-intensive model mean wage inflation or a transactional slowdown can erase a large share of earnings, as Q2's $365 million operating income (3.25% margin) versus Q3's $561 million demonstrates. Second is valuation compression — the 41.44x trailing PE and 22.02x EV/EBITDA depend on the $13.48 forward EPS arriving, and a miss would force a de-rating toward the 12x historical floor seen in Q3 2022. Third is macro and rate sensitivity: beta of 1.227 makes CBRE roughly 23% more volatile than the market, and elevated rates that stall CRE capital-markets activity hit the highest-margin advisory line directly, already visible in the -23.24% YTD relative strength versus the S&P. Fourth is company-specific execution — the Onnec integration carries undisclosed accretion and data-center backlog assumptions, and leverage of 1.125x debt-to-equity with a 1.095 current ratio leaves limited cushion if the deal underperforms.
The three-scenario framework assigns 50% to a base case of $141–$172, 30% to a bull case of $172–$200, and 20% to a bear case of $121–$141. The base case is most likely: it assumes consensus revenue of $62.2 billion and EPS of $13.48 are broadly met, gross margin holds in the 17%–18.5% band, and the stock grinds back toward the $172 average target as the 15.29x forward multiple is validated, remaining range-bound between $121 support and $155 resistance until capital-markets activity visibly inflects. The bull case requires a CRE recovery plus quantified Onnec accretion and operating margin above 5%, letting the stock reclaim $150–$155 and reach the $172 average with the $200 high target achievable on accelerating AI data-center demand. The bear case is a CRE credit event or volume stall that breaks the $121.44 low and compresses the multiple toward 12x, though even the mild version lands near the $141 analyst low — only about -10% to -11% from current levels.
The answer depends entirely on which earnings base you use, and that is the crux of the debate. On trailing figures CBRE looks expensive — 41.44x PE, 22.02x EV/EBITDA, 30.75x price-to-cash-flow, 5.40x book (near the top of its 2.7x–5.5x historical band) and a 1.82 PEG — but on the $13.48 consensus EPS the forward PE collapses to 15.29x, a 63% compression that would put it at a discount to broad market multiples. Price-to-sales of 1.18x and EV/sales of 1.09x are modest for a 12%+ grower and sit near the low end of the multi-year 2.9x–4.6x range, a divergence that reflects earnings compression rather than a sales collapse. What the market is implicitly pricing is a normalization of earnings power through margin recovery and Onnec accretion; if that materializes the stock is undervalued, and if margin pressure persists the trailing multiple is a warning. Net verdict: undervalued on forward earnings and relative to its own sales history, fairly-to-richly valued on trailing cash flow.
On a risk/reward basis the setup is asymmetric in the buyer's favor: at $135.51 the stock trades below the lowest of 13 analyst targets ($141.00, +4.1%) and 26.9% below the $172.00 average, with 12 Buy ratings against 1 Hold and 0 Sell. The upside case is anchored by a 15.29x forward PE on $13.48 consensus EPS versus a 41.44x trailing multiple, while the downside is defined by the $121.44 52-week low — roughly -10.4% — and a deeper multiple-compression scenario toward the 12x historical PE floor that could cost -25% to -30%. The biggest risk is that the earnings step-up embedded in the forward multiple does not arrive, because net margin is only 3.85% and gross margin has swung between 15.29% and 18.58% over four quarters. It is a good buy for investors with a 12–18 month horizon who can tolerate a retest of $121 and want cyclical CRE recovery exposure with an AI data-center kicker; it is a poor buy for anyone needing income (zero dividend) or low volatility (beta 1.227).
CBRE is better suited to a medium-to-long-term hold than to short-term trading, though its beta of 1.227 and 29.11% max drawdown make it a volatile position that requires tolerance for drawdowns. The long-term case rests on the platform's scale (155,000 employees, 100+ countries), 13.03% ROE, $938 million TTM free cash flow, and a forward PE of 15.29x that offers a margin of safety if the cyclical recovery plays out; the Onnec data-center pivot adds a multi-year AI infrastructure growth vector. The short-term case is weaker: the stock is down 15.41% YTD and 9.65% over one year, sits at only 26.6% of its 52-week range, and the recent +11.22% one-month relative strength versus SPY is a mean-reversion bounce within an intact intermediate downtrend rather than a confirmed reversal. With no dividend (payout ratio 0) and lumpy cash flow that swung from -$825 million in Q1 to $869 million in Q3, there is no income or stability argument for a short holding period. A suggested minimum holding period is 12–18 months, long enough for the Q4 2026 and Q1 2027 earnings to validate or refute the $13.48 EPS consensus.

